News
Regeneron Just Bought Your DNA From 23andMe
Digest more
Tarrytown-based Regeneron Pharmaceuticals, Inc. has announced it has been named the successful bidder in the bankruptcy ...
Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D. Find out why REGN stock is a Buy.
4d
Stocktwits on MSNRegeneron To Buy Assets Of 23andMe For $256M: Retail Says ‘Fantastic’ For Future R&D EffortsDrugmaker Regeneron Pharmaceuticals, Inc. (REGN) said on Monday that it will acquire the assets of bankrupt biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results